Tevasil

Active

Silybum marianum (L.) Gaertn. Milk thistle · Vegetables

also searched as: тевасил

Variety description

10 August 2026

The variety is intended for industrial cultivation with the aim of obtaining plant raw materials for the production of hepatoprotective drugs. The chemical profile of the seeds is characterized by a specific composition of flavonolignans, among which silychristin, silybin A, silybin B, and isosilybin A predominate.

The plant possesses unique morphological traits and a vegetation period distinct from other breeding varieties of Silybum marianum. Detailed data on growth parameters, yield, and lodging resistance are not specified, as the primary requirement for the variety is uniformity of phytochemical composition.

Sources5

Loading…

The list of sources is loaded via script—please enable JavaScript.

Countries of admission

1 jurisdiction

Green indicates countries where the variety is listed in the national catalogue and its seeds are authorized for sale. Expired registrations are marked separately: the variety was previously admitted, but sale is no longer permitted.

IS FI NO SE EE IE GB DK LV LT NL DE PL BY PT ES FR BE CZ SK UA RU LU CH AT HU MD IT SI HR RS RO MT GR BG CY

active no record

Variety in registries Regions of admission, rights holders, and status of plant breeders' rights

Parties

Applicant: Teva Czech Industries s.r.o. (CZ) 3 Submitted the application to the register
Rights holder: Univerzita Palackého v Olomouci (CZ)/TAPI Czech Industries s.r.o. (CZ) Holds the rights to the variety
Maintainer: TAPI Czech Industries s.r.o. (CZ) 4 Responsible for variety maintenance

Plant breeders' rights

The right is granted for a limited term: propagation of the variety requires a license from the rights holder.

Czechia № 2225

Active

Application filed 8 March 2013
Registered 5 June 2015
Currently active indefinite in the register

Records are sourced from official registry publications. Data sources and legal status

Found an error in the record?

The directory replicates the primary source. If an entry differs from the official publication, please specify the discrepancy and provide a link if possible. Corrections are added to the moderation queue.